Pharmaceutical companies with the most ‘Antibiotic GAIN Act’ drugs

This chart shows the companies which have received the most GAIN Act exclusivities in the past five years. The Generating Antibiotic Incentives Now Act provides for five years of market…
The post Pharmaceutical companies with the most ‘Antibiotic GAIN …


New patent for Boehringer Ingelheim drug SYNJARDY

Annual Drug Patent Expirations for SYNJARDY Synjardy is a drug marketed by Boehringer Ingelheim and is included in two NDAs. It is available from one supplier. There are six patents…
The post New patent for Boehringer Ingelheim drug SYNJARDY appeared f…


Biotechblog